For 150 years, cancer diagnosis has been limited to the subjective interpretation of what the human eye could see under a microscope. To change the way we diagnose and research cancer, we need new tools — computational applications that leverage AI and machine learning — to show us the information hidden in every tissue sample.

That’s why we started Proscia. Our mission is to perfect cancer diagnosis with intelligent software that changes the way the world practices pathology. We’re building tools for the mind that are redefining pathology and giving pathologists better ways to fight cancer today.

Company Highlights

  • Founded in Baltimore, MD in 2014
  • Headquarters in Philadelphia, PA
  • 6 major academic research centers partner with Proscia
  • 5,000+ pathologists and scientists use Concentriq
  • Collaborating with 12+ clinical AI partners with access to over 1M whole slide images for AI research
  • Integration with all major whole slide image scanners and LIS applications
  • 4 U.S. patents granted
  • $35.3M raised to date
Funded By

Partners Against Cancer

At Proscia, the patient remains the driving force behind our mission. We are proud to work with the American Cancer Society as a Partner Against Cancer to help improve access to treatment for those who need it. Proscia has made a commitment to the ACS Hope Lodge Program, an important initiative that provides free lodging for patients in more than 30 locations across the United States and Puerto Rico.

Partner with Proscia

With a unified laboratory ecosystem, Concentriq is driving economic and clinical value for a growing list of hardware and software partners. See what kind of opportunities we can unlock for your company.

ABOUT PARTNERSHIPSLink Arrow

Join the fight against cancer

A career at Proscia means effecting real change for pathologists and the way humans understand and diagnose cancer. Bring your passion to a workplace where nothing is impossible.

Jobs At ProsciaLink Arrow

Our website uses cookies. By using this site, you agree to its use of cookies.